The small splice variant of tenascin-C (TN) has eight fibronectin type III (FN3) domains. The major large splice variant has three (in chicken) or seven (in human) additional FN3 domains inserted between domains five and six. Chiquet-Ehrismann et al. (Chiquet-Ehrismann, R., Matsuoka, Y., Hofer, U., Spring, J., Bernasconi, C., and Chiquet, M. (1991, Cell Regul. 2, 927-938) demonstrated that the small variant bound preferentially to fibronectin in enzyme-linked immunosorbent assay, and only the small variant was incorporated into the matrix by cultures of chicken fibroblasts. Here we have studied human TN, and confirmed that the small variant binds preferentially to purified fibronectin and to fibronectin-containing extracellular matrix. Thus this differential binding appears to be conserved across vertebrate species. Using bacterial expression proteins, we mapped the major binding site to the third FN3 domain of TN. Consistent with this mapping, a monoclonal antibody against an epitope in this domain did not stain TN segments bound to cell culture matrix fibrils. The enhanced binding of the small TN variant suggests the existence of another, weak binding site probably in FN3 domains 6-8, which is only positioned to bind fibronectin in the small splice variant. This binding of domains 6-8 may involve a third molecule present in matrix fibrils, as the enhanced binding of small TN was much more prominent to matrix fibrils than to purified fibronectin.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				K. E. Keller, J. M. Bradley, M. J. Kelley, and T. S. Acott Effects of Modifiers of Glycosaminoglycan Biosynthesis on Outflow Facility in Perfusion Culture Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2495 - 2505. [Abstract] [Full Text] [PDF]

				J. Sottile, F. Shi, I. Rublyevska, H.-Y. Chiang, J. Lust, and J. Chandler Fibronectin-dependent collagen I deposition modulates the cell response to fibronectin Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1934 - C1946. [Abstract] [Full Text] [PDF]

				K. C. Ingham, S. A. Brew, and H. P. Erickson Localization of a Cryptic Binding Site for Tenascin on Fibronectin J. Biol. Chem., July 2, 2004; 279(27): 28132 - 28135. [Abstract] [Full Text] [PDF]

				J. Sottile and D. C. Hocking Fibronectin Polymerization Regulates the Composition and Stability of Extracellular Matrix Fibrils and Cell-Matrix Adhesions Mol. Biol. Cell, October 1, 2002; 13(10): 3546 - 3559. [Abstract] [Full Text] [PDF]

				F. Coussen, D. Choquet, M. P. Sheetz, and H. P. Erickson Trimers of the fibronectin cell adhesion domain localize to actin filament bundles and undergo rearward translocation J. Cell Sci., June 15, 2002; 115(12): 2581 - 2590. [Abstract] [Full Text] [PDF]

				M. Pereira, B. J. Rybarczyk, T. M. Odrljin, D. C. Hocking, J. Sottile, and P. J. Simpson-Haidaris The incorporation of fibrinogen into extracellular matrix is dependent on active assembly of a fibronectin matrix J. Cell Sci., January 2, 2002; 115(3): 609 - 617. [Abstract] [Full Text] [PDF]

				W. Huang, R. Chiquet-Ehrismann, J. V. Moyano, A. Garcia-Pardo, and G. Orend Interference of Tenascin-C with Syndecan-4 Binding to Fibronectin Blocks Cell Adhesion and Stimulates Tumor Cell Proliferation Cancer Res., December 1, 2001; 61(23): 8586 - 8594. [Abstract] [Full Text] [PDF]

				M. D. Puente Navazo, D. Valmori, and C. Ruegg The Alternatively Spliced Domain TnFnIII A1A2 of the Extracellular Matrix Protein Tenascin-C Suppresses Activation-Induced T Lymphocyte Proliferation and Cytokine Production J. Immunol., December 1, 2001; 167(11): 6431 - 6440. [Abstract] [Full Text] [PDF]

				M. B. Wenk, K. S. Midwood, and J. E. Schwarzbauer Tenascin-C Suppresses Rho Activation J. Cell Biol., August 21, 2000; 150(4): 913 - 920. [Abstract] [Full Text] [PDF]

				U. Zacharias, U. Norenberg, and F. G. Rathjen Functional Interactions of the Immunoglobulin Superfamily Member F11 Are Differentially Regulated by the Extracellular Matrix Proteins Tenascin-R and Tenascin-C J. Biol. Chem., August 20, 1999; 274(34): 24357 - 24365. [Abstract] [Full Text] [PDF]

				J. Talts, G Wirl, M Dictor, W. Muller, and R Fassler Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer J. Cell Sci., January 6, 1999; 112(12): 1855 - 1864. [Abstract] [PDF]

				J. A. Luczak, S. D. Redick, and J. E. Schwarzbauer A Single Cysteine, Cys-64, Is Essential for Assembly of Tenascin-C Hexabrachions J. Biol. Chem., January 23, 1998; 273(4): 2073 - 2077. [Abstract] [Full Text] [PDF]

				U. Rauch, A. Clement, C. Retzler, L. Frohlich, R. Fassler, W. Gohring, and A. Faissner Mapping of a Defined Neurocan Binding Site to Distinct Domains of Tenascin-C J. Biol. Chem., October 24, 1997; 272(43): 26905 - 26912. [Abstract] [Full Text] [PDF]

				R. A. Clark, H. P. Erickson, and T. A. Springer Tenascin Supports Lymphocyte Rolling J. Cell Biol., May 5, 1997; 137(3): 755 - 765. [Abstract] [Full Text] [PDF]

				C. Chung and H. Erickson Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C J. Cell Sci., January 6, 1997; 110(12): 1413 - 1419. [Abstract] [PDF]

				S. Schumacher, M. Jung, U. Norenberg, A. Dorner, R. Chiquet-Ehrismann, C. A. O. Stuermer, and F. G. Rathjen CALEB Binds via Its Acidic Stretch to the Fibrinogen-like Domain of Tenascin-C or Tenascin-R and Its Expression Is Dynamically Regulated after Optic Nerve Lesion J. Biol. Chem., March 2, 2001; 276(10): 7337 - 7345. [Abstract] [Full Text] [PDF]